The effect of anticancer drugs on seven cell lines monitored by FTIR spectroscopy.
暂无分享,去创建一个
Erik Goormaghtigh | E. Goormaghtigh | M. Verdonck | Allison Derenne | Allison Derenne | Magali Verdonck
[1] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[2] Robert Kiss,et al. IR spectroscopy as a new tool for evidencing antitumor drug signatures. , 2009, Biochimica et biophysica acta.
[3] Henry H. Mantsch,et al. The medical challenge to infrared spectroscopy , 1997 .
[4] Max Diem,et al. Infrared Spectroscopy of Cells and Tissues: Shining Light onto a Novel Subject , 1999 .
[5] K. Kohno,et al. Possible involvement of multidrug‐resistance‐associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells , 1994, International journal of cancer.
[6] Ganesh D. Sockalingum,et al. IR spectroscopy reveals effect of non-cytotoxic doses of anti-tumour drug on cancer cells , 2009, Analytical and bioanalytical chemistry.
[7] R. Kiss,et al. Fourier transform infrared (FTIR) spectroscopy to monitor the cellular impact of newly synthesized platinum derivatives. , 2010, International journal of oncology.
[8] Goormaghtigh Erik,et al. SUBTRACTION OF ATMOSPHERIC WATER CONTRIBUTION IN FOURIER TRANSFORM INFRARED SPECTROSCOPY OF BIOLOGICAL MEMBRANES AND PROTEINS , 1994 .
[9] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[10] P. Lasch,et al. FT-IR spectroscopic investigations of single cells on the subcellular level , 2002 .
[11] D. Naumann,et al. Classification and identification of bacteria by Fourier-transform infrared spectroscopy. , 1991, Journal of general microbiology.
[12] P. Choong,et al. Review: doxorubicin delivery systems based on chitosan for cancer therapy , 2009 .
[13] E. Goormaghtigh,et al. Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. II. Experimental aspects, side chain structure, and H/D exchange. , 1994, Sub-cellular biochemistry.
[14] P. Morris,et al. Microtubule Active Agents: Beyond the Taxane Frontier , 2008, Clinical Cancer Research.
[15] A. Negi,et al. Plant-based anticancer molecules: a chemical and biological profile of some important leads. , 2005, Bioorganic & medicinal chemistry.
[16] M. Diem,et al. Infrared spectroscopy of human tissue. V. Infrared spectroscopic studies of myeloid leukemia (ML-1) cells at different phases of the cell cycle. , 1999, Biospectroscopy.
[17] B. Rigas,et al. Cytologically normal cells from neoplastic cervical samples display extensive structural abnormalities on IR spectroscopy: implications for tumor biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] Matej Oresic,et al. Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. , 2011, Cancer research.
[19] E. Goormaghtigh,et al. Effects of the confluence rate on the FTIR spectrum of PC-3 prostate cancer cells in culture. , 2010, The Analyst.
[20] W. Berger,et al. The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cells. , 2009, Cancer letters.
[21] H. Adwan,et al. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells. , 2010, International journal of oncology.
[22] Y. Choi,et al. Metabolomics: a tool for anticancer lead-finding from natural products. , 2010, Planta medica.
[23] Simone Rochfort,et al. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. , 2005, Journal of natural products.
[24] E. Goormaghtigh,et al. Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes. , 1999, Biochimica et biophysica acta.
[25] R. Reissbrodt,et al. Differentiation between probiotic and wild-type Bacillus cereus isolates by antibiotic susceptibility test and Fourier transform infrared spectroscopy (FT-IR). , 2010, International journal of food microbiology.
[26] S. Spiegl-Kreinecker,et al. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. , 2009, Journal of medicinal chemistry.
[27] Harald Labischinski,et al. Microbiological characterizations by FT-IR spectroscopy , 1991, Nature.
[28] Y. Choi,et al. Metabolomics for bioactivity assessment of natural products , 2011, Phytotherapy research : PTR.
[29] Erik Goormaghtigh,et al. The FTIR spectrum of prostate cancer cells allows the classification of anticancer drugs according to their mode of action. , 2011, The Analyst.
[30] J. H. Ward. Hierarchical Grouping to Optimize an Objective Function , 1963 .
[31] B. Wood,et al. FTIR microspectroscopic study of cell types and potential confounding variables in screening for cervical malignancies. , 1998, Biospectroscopy.
[32] R. Kiss,et al. The infrared spectrum of human glioma cells is related to their in vitro and in vivo behavior. , 2004, Experimental cell research.
[33] R. Kiss,et al. FTIR spectral signature of the effect of cardiotonic steroids with antitumoral properties on a prostate cancer cell line. , 2010, Biochimica et biophysica acta.
[34] J. Dichgans,et al. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo , 2000, Acta Neuropathologica.
[35] Franck Bonnier,et al. Evaluation of the potential of Raman microspectroscopy for prediction of chemotherapeutic response to cisplatin in lung adenocarcinoma. , 2010, The Analyst.
[36] Lisa Vaccari,et al. Synchrotron FTIR analysis of drug treated ovarian A2780 cells: an ability to differentiate cell response to different drugs? , 2011, The Analyst.